Skip to main content
Premium Trial:

Request an Annual Quote

PreventionGenetics to Use GoldenHelix's VarSeq for Dx Test Offering

NEW YORK (GenomeWeb) – Golden Helix has signed an agreement with PreventionGenetics that allows the latter to implement Golden Helix's VarSeq software into its exome sequencing pipeline.

PreventionGenetics will use the solution to analyze data from an exome sequencing test for clinical diagnostics that the company is preparing to launch in mid-2015. The software streamlines the process of annotating and filtering variants from next-generation sequencing data. It features a simple user interface and scalable architecture with repeatable workflows, tools for note taking and reporting, and filter parameter prototyping.

VarSeq "will allow us to move forward with offering an exome test" by providing tools "to take abundant sequence from exome data and efficiently translate that into molecular diagnoses," Jerry Machado, a clinical molecular geneticist at PreventionGenetics, said in a statement.

Financial and other terms of the agreement were not disclosed.

 

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.